Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale-Reference-Cited by-同舟云学术

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale

Published:2017-11 Issue: Volume:86 Page:106-114
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Casadei Gardini Andrea^ORCID,Faloppi Luca,De Matteis Serena,Foschi Francesco Giuseppe,Silvestris Nicola,Tovoli Francesco,Palmieri Vincenzo,Marisi Giorgia,Brunetti Oronzo,Vespasiani-Gentilucci Umberto,Perrone Giuseppe,Valgiusti Martina,Granato Anna Maria,Ercolani Giorgio,Negrini Giulia,Tamburini Emiliano,Aprile Giuseppe,Passardi Alessandro,Santini Daniele,Cascinu Stefano,Frassineti Giovanni Luca,Scartozzi Mario

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity;Seeff;Oncogene,2006

2. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States;El-Serag;Hepatology,2001

3. Hepatocellular carcinoma: recent trends in the United States;El-Serag;Gastroenterology,2004

4. The evolutionary scenario of hepatocellular carcinoma in Italy: an update;Bucci;Liver Int,2017

5. Hepatocarcinoma: genetic and epigenetic features;Lombardi;Minerva Gastroenterol Dietol,2017

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab;Scientific Reports;2024-08-30

2. Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion;Cellular Oncology;2024-07-11

3. Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma;Cell Death & Disease;2024-06-05

4. Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib;Gastroenterology Research;2024-02

5. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections;Journal of Cancer Metastasis and Treatment;2024-01-23